TrialAntiviral research2013

Safety of coitally administered tenofovir 1% gel, a vaginal microbicide, in chronic hepatitis B virus carriers: results from the CAPRISA 004 trial.

Cheryl Baxter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.